drugset / Trial / NCT01613209
Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine
NaSingle-groupOpen-labelTreatment
Summary
The investigators want to find out whether a recently introduced combination of two blood pressure lowering agents (olmesartan and amlodipine) has a different blood pressure lowering effect than a single active substance. In addition the investigators want to find out whether there is a difference in the changes in blood pressure over the course of a day depending on the time when the medications are taken (in the morning or at night). Male and female patients over 18 years of age may participate.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-09
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | Candesartan cilexetil | Unknown | 32 mg | Oral |
| Subject | Olmesartan | Other / unclassified | 40 mg | Oral |